What are ResMed's profit margins?

ResMed (RMD) runs a 61.6% gross margin and a 34.2% operating margin, with a 27.4% net margin.

Where do ResMed's ratios come from?

Every ratio is computed from ResMed's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

ResMed RMD Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q3 '26	TTM Q2 '26	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25
Profitability
Gross margin	241.9%+10.4pp	239.1%+10.6pp	236.6%+11.4pp	234.2%+11.4pp	231.5%+9.6pp
Operating margin	133.8%+12.4pp	131.7%+15.9pp	129.7%+20.2pp	126%+19.9pp	121.4%+16.7pp
Net margin	109.5%+13.1pp	108.2%+17.1pp	106.1%+20.5pp	101.9%+18.7pp	96.4%+13.8pp
EBITDA margin	149.3%+13.2pp	146.8%+16.0pp	144.6%+19.7pp	140.7%+18.9pp	136.1%+15.5pp
Free cash flow margin	130.8%+15.4pp	130.4%+22.4pp	125.4%+24.3pp	119.9%+28.4pp	115.4%+38.1pp
Returns
Return on equity	102.2%+4.5pp	102.8%+8.5pp	102.7%+12.4pp	100.9%+10.5pp	97.7%+6.1pp
Return on assets	74.7%+7.7pp	74.4%+11.5pp	73.2%+15.0pp	70.6%+13.1pp	67%+9.3pp
Return on invested capital	102.6%+15.8pp	100.4%+20.1pp	97.3%+22.9pp	92.7%+19.6pp	86.8%+13.7pp
Efficiency
Asset turnover	2.7×0.0×	2.7×0.0×	2.8×0.0×	2.8×0.0×	2.8×0.0×
Inventory turnover	9.4×+0.3×	9.4×+0.6×	9.3×+0.6×	9.3×+0.6×	9.1×+0.5×
Liquidity
Current ratio	12.4×+0.1×	12.8×+0.9×	13.1×+1.4×	13.1×+1.4×	12.3×0.0×
Quick ratio	9.3×+0.9×	9.5×+1.6×	9.5×+2.0×	9.2×+1.9×	8.4×+1.0×
Cash ratio	4.7×+2.3×	4.4×+2.8×	3.9×+2.6×	3.3×+2.1×	2.3×+1.2×
Leverage
Debt-to-equity	0.7×0.0×	0.7×-0.1×	0.6×-0.3×	0.6×-0.5×	0.7×-0.6×
Debt-to-assets	0.5×0.0×	0.5×-0.1×	0.5×-0.2×	0.5×-0.3×	0.5×-0.4×
Net debt / EBITDA	-0.7×-1.6×	-0.5×-2.1×	-0.2×-2.5×	0.2×-2.8×	0.8×-2.8×
Interest coverage	661.9×—	——	——	——	——
Per Share
Book value per share	$169.91+20.1%	$163.03+20.6%	$155.46+19.6%	$148.99+20.6%	$141.45+19.3%
Valuation
Market capitalization	$145.46B+11.5%	$145.64B+15.0%	$144.05B+21.7%	$139.84B+34.1%	$130.44B+20.5%
Enterprise value	$143.97B+9.3%	$144.62B+12.1%	$143.67B+18.1%	$140.17B+29.3%	$131.77B+16.5%
Price / earnings	99.8×-11.9×	103.4×-13.7×	106.6×-12.0×	110.9×+0.6×	111.7×-6.9×
Price / sales	27.3×+0.5×	28×+1.3×	28.3×+2.8×	28.1×+5.2×	26.8×+2.3×
Price / book	23.4×-1.6×	24.3×-1.0×	25.2×+0.5×	25.5×+2.7×	25×+0.2×
EV / EBITDA	72.6×-7.2×	75.7×-7.3×	78×-5.6×	80.3×+2.0×	79.8×-5.1×
EV / sales	27.1×0.0×	27.8×+0.7×	28.2×+2.1×	28.2×+4.3×	27.1×+1.5×
Free cash flow yield	19.3%+2.0pp	18.7%+2.4pp	17.8%+1.8pp	17.1%+1.2pp	17.3%+4.2pp
Earnings yield	16.2%+1.7pp	15.5%+1.8pp	15%+1.5pp	14.6%-0.1pp	14.4%+0.7pp
Dividend yield	3.6%0.0pp	3.5%-0.2pp	3.4%-0.4pp	3.4%-0.8pp	3.6%-0.4pp
PEG ratio	4.3×-0.5×	3.6×-3.2×	3×-6.0×	3.5×-5.7×	4.8×-4.8×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about ResMed.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are ResMed's profit margins?: ResMed (RMD) runs a 61.6% gross margin and a 34.2% operating margin, with a 27.4% net margin.
Where do ResMed's ratios come from?: Every ratio is computed from ResMed's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.